InternationalUSRemember you can easily switch between MIP US and MIP International at any time

APRAM reacts to plain packaging proposals


From December 1, Australia will adopt plain packaging for tobacco products – a standardised pack on which is printed the trade mark in standard size, font and place, with no logo and no colour. The aim is to knock out the attractive appearance of the packaging, supposedly suggesting a "glamorous" world of tobacco.

This subject is under consideration in Europe: a revision of the Directive related to tobacco products is being contemplated by the European Commission. The UK, like all...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Our latest (sponsored) country updates - from Africa to Vietnam - are free to view online http://t.co/vbv61995jG and on the iPhone/iPad app

May 29 2015 09:23 ·  reply ·  retweet ·  favourite
ManagingIP profile

@LexBlog @Mayer_Brown Congratulations to all of them! @IP_STARS

May 29 2015 09:15 ·  reply ·  retweet ·  favourite
ManagingIP profile

Re @uspto @Columbia event (earlier tweet) on June 9, use the code PTOcomp-55 to save $55 on registration until June 5 http://t.co/ZgWY0Lx5sy

May 28 2015 04:58 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements